Latest Headlines

  1. FDA Clears Intuitive Surgical’s Ion Endoluminal System

    Intuitive Surgical, Inc. (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) cleared the Ion™ endoluminal system to enable minimally invasive biopsy in the peripheral lung.

  2. Medtronic’s Personalized Closed Loop Insulin Pump System Earns FDA Breakthrough Designation

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Personalized Closed Loop (PCL) insulin pump system, currently in development. The PCL technology is designed to automate insulin delivery in a way that is real-time, personalized and adapts to the user.

  3. NuVasive Gains FDA Clearance, CE Mark For Its All-Internal Precice Bone Transport System

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) – as well as European CE mark approval – for use of its Precice® Bone Transport System, the only all-internal system of its kind on the market indicated for use in segmental bone loss treatment in the tibia and femur resulting from trauma or infection.

  4. FDA Clears Fresenius Kabi’s Fenwal Amicus Red Blood Cell Exchange System

    Fresenius Kabi recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration for the Fenwal Amicus Red Blood Cell Exchange (RBCx) system.

  5. MKS Announces Ophir® Integrating Spheres For Accurate, Repeatable Measurement Of Optical Power In VCSELs

    MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, has announced at SPIE Photonics West the Ophir® IS6D integrating spheres for measuring the optical power of widely divergent laser diode sources, such as VCSELs. Part of the Ophir Integrating Spheres series of products, the new spheres can accurately measure light that diverges up to ±85 degrees. Each sphere is delivered as a calibrated unit with a photodiode detector.

  6. MKS Announces Ophir® BeamWatch® Integrated, Fully Automated Beam Monitoring System For Industrial Production Environments

    MKS Instruments, Inc., a global provider of technologies that enable advanced processes and improve productivity, has announced at SPIE Photonics West Ophir® BeamWatch® Integrated, a fully automated, non-contact laser measurement system designed to measure critical beam parameters in industrial production environments. A rugged, compact, self-contained system, BeamWatch Integrated measures parameters of the focused beam in real-time, including focus spot size, beam caustic, and absolute power readings. The system can accommodate different types of welding heads and includes a variety of interfaces, such as PROFINET and Ethernet/IP, for integration into production networks and automated manufacturing lines to facilitate direct transfer of measurement data.

  7. J&J’s Ethicon To Acquire Auris Health For $3.4B

    Focused on creating the next frontier of surgery, Johnson & Johnson, recently announced that Ethicon, Inc., entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4B in cash. Additional contingent payments of up to $2.35B, in the aggregate, may be payable upon reaching certain predetermined milestones.

  8. Edwards Lifesciences To Acquire CASMED For $100M

    Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has entered into a definitive merger agreement to acquire CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a medical technology company dedicated to non-invasive monitoring of tissue oxygenation in the brain.

  9. FDA Clears Zimmer Biomet’s ROSA One Brain Application

    Zimmer Biomet has received U.S. Food and Drug Administration (FDA) clearance for the ROSA One Brain Application, a robotic surgical navigation and positioning system for use in neurosurgical procedures.

  10. Office-based, Non-invasive Prostate Cancer Treatment Wins 2019 SPIE Startup Challenge At Photonics West

    A technology company that aims to shift prostate-cancer treatment from an invasive surgical setting to a brief, office-based visit, won the top award at the 9th annual SPIE Startup Challenge at Photonics West on Wednesday, 6 February